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httpcense.Abstract Background: Reactivation of cytomegalovirus (CMV) has been reported in critically ill
patients (especially elderly) lying in the intensive care units. So identifying such patients to treat is
important.
The aim of this study: To detect the frequency of CMV infection in mechanically ventilated
patients, and its correlation with patients’ risk factors, and outcomes.
Subjects and methods: The present study was carried out on 51 mechanically ventilated patients
admitted to the Respiratory (20) and Geriatric ICU (31) of the Ain Shams University hospitals over
a 3 month period. Serum CMV load was measured by real-time PCR.
Results: The overall rate of active CMV infection by RT-PCR among the studied populations
was (68.6%), (77.4%) in patients of geriatric ICU versus (55%) in respiratory ICU patients. Com-
parison between CMV positive and negative cases showed a signiﬁcant difference in the duration of
mechanical ventilation and mortality rate. A statistically higher CMV load was recorded in respi-
ratory ICU patients admitted due to exacerbation of chronic respiratory disease or stroke and
developing ventilator associated pneumonia (VAP) or septic shock. Also there was a signiﬁcant
direct correlation between CMV load and age of the patient, duration of mechanical ventilation
and duration of ICU stay.87668, +20 1223549008.
com (N.M. Osman).
e Egyptian Society of Chest
g by Elsevier
of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
://dx.doi.org/10.1016/j.ejcdt.2013.09.022
240 N.M. Osman et al.Conclusion: CMV infection is frequent in mechanically ventilated critically ill patients espe-
cially the elderly. It is associated with poor outcomes, leads to increased mortality and morbidity
in terms of increased ICU stay, longer duration of mechanical ventilation, and higher rates of
nosocomial infections.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
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Cytomegalovirus (CMV) is a major b herpes virus, latently
persisting in the majority of the adult human population
worldwide. Infection is common with seroprevalence rates
increasing steadily from 65% among 40–49 year olds to 91%
in those aged 80 years or over [1]. It has been suggested that
chronic CMV infection is a driving force in age related T cell
immunosenescence [2]. It has increasingly come to be recog-
nized that critically ill patients who are traditionally consid-
ered immunocompetent may also be at risk for CMV
infection. Reactivation from the latency rather than primary
infection is believed to be the cause of CMV infection [3].
CMV serology is not useful for the diagnosis of active infec-
tions and its culture is impractical for clinical purposes.
Real-time PCR is a sensitive, speciﬁc and reliable marker to
monitor the clearance of viremia [4].
The presence of CMV infection in critically ill patients was
associated with a signiﬁcant increase in morbidity and mortal-
ity, although this infection might be self-limited with spontane-
ous resolution within 2–3 weeks after reactivation [5]. Several
studies showed that a CMV infection in this population was
associated with prolonged ventilator support, high rates of
nosocomial infections and prolonged hospital and/or ICU
stay. However, the impact of CMV infection on the outcome
of those patients is still debated [4].
The aim of the current study was to detect the frequency of
CMV infection in mechanical ventilated patients, and its corre-
lation with patients’ risk factors, and outcomes, aiming to
evaluate the need for screening for CMV infection.
Subjects and methods: This prospective study was per-
formed in the Respiratory and Geriatric ICU of the Ain Shams
University hospitals. Over a 3 month period, 20 patients were
admitted to the Respiratory ICU and 31 patients were admit-
ted to Geriatric ICU. All consecutive patients (18 years or old-
er) were included in this study if they were mechanically
ventilated.
Exclusion criteria: Patients were not included if they were
pregnant, HIV positive, had solid organ or bone marrow
transplantation, had received immunosuppressive agents or,
long-term treatment with corticosteroids (h 3 months), had
solid cancer or hematologic malignancy with previous antican-
cer radiotherapy or chemotherapy.
Baseline assessment and data collection
Informed consent was taken either from patients’ relatives or
their guardians before the start of this study. Each patient’s
hospital chart was prospectively implemented, and the follow-
ing data were recorded during admission to the ICU: age, sex,
presence of co-morbidities {diabetes mellitus (DM) and/orrenal diseases}, Main cause of ICU admission; the time spent
on a mechanical ventilator, and duration of ICU admission.
Other relevant clinical characteristics and outcomes complicat-
ing the ICU stay as {adult respiratory distress syndrome
(ARDS), ventilator-associated pneumonia (VAP), septic
shock, and mortality} were also recorded throughout the
ICU stay. Peripheral venous blood samples were collected;
serum was separated and stored at 80 C till use in PCR
analysis.
Identiﬁcation of CMV by real time PCR
The presence of CMV was tested with a quantitative real-time
PCR. DNA was extracted from serum samples using a Qiagen
kit (Qiagen, Valencia, CA, USA) and quantiﬁed using the
standard laboratory protocol recommended by the manufac-
turer’s instructions. Quantitative real for CMV was performed
using a light Cycler H Instrument (Roche Diagnostics, Mey-
lan, France) with the QuantiTect Probe PCR Kit (Qiagen).
The presence of CMV was tested with forward primer
(50GCAGCCACGGGATCGTACT-30) and the reverse primer
(50GGCTTTTACCTCACACGAGCATT-30), and the speciﬁc
TaqMan probe (6FAM-CGCGAGACCGTGGAACTGCG-
TAMRA) according to Coisel et al. [6]. The reaction was
carried out in 20 mL, in a ﬁnal volume containing 10 mL of
QuantiTect master mix, 0.2 mM of probe, 0.2 mM of each pri-
mer, and 4 mL of DNA. The PCR was initiated by an enzyme-
activation incubation at 95 C for 15 min to activate DNA
Polymerase, followed by 40 cycles of denaturation at 95 C
for 10 s and an annealing-extension step at 60 C for 1 min. Se-
rial dilutions, ranging from 102 to 105 copies/ml of synthesized
sequences that correspond to the targeted viral genes, were
used as positive controls. These dilutions were also used to
determine the viral load in positive samples. A CMV negative
specimen was used as a negative control sample was considered
positive by real-time PCR if it crossed the threshold.
Data management and statistical analysis
Quantitative data are presented as mean and SD for paramet-
ric data or median for non-parametric data and categorical
data are presented as numbers of cases and percentages.
Student T and Mann Whitney tests were used to assess the sta-
tistical signiﬁcance of the difference between the two groups
regarding Quantitative data. Chi square and Fisher’s exact
tests were used to examine the relationship between Categori-
cal variables. Spearman’s correlation coefﬁcient was used to
assess the correlation between quantitative variables. A signif-
icance level of P< 0.05 was used in all tests. All statistical
procedures were carried out using SPSS version 15 for
Windows (SPSS Inc, Chicago, IL, USA).
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Patients characteristics
This study was conducted on 51 mechanically ventilated
patients, over a 3 month period, 20 patients were admitted to
the Respiratory ICU and 31 patients were admitted to Geriat-
ric ICU of the Ain Shams University hospitals. Their age was
ranging from (33–81) years with mean (58.7 ± 12.7), 29 males
(56.9%) and 22 females (43.1%).
As regards the different causes of ICU admission, patients
with exacerbation of chronic respiratory disease were 33
(64.7%), patients with stroke were 11 (21.6%), patients with
cardiac diseases were 8 (15.7%) and patients with other causes
(hepatic failure, dehydration and electrolyte disturbance) were
3 (5.9%). Sixteen patients (31.4%) were diabetics while 17
(33.3%) had associated renal disease.
The overall duration of mechanical ventilation ranged from
(1–12 days) with mean (3.94 ± 2.86) and median (3 days),
while the duration of ICU stay ranged from (1–30 days) with
mean (6.94 ± 6.11) and median (5 days).
As regards patient outcome, 6 patients (11.8%) developed
septic shock, 15 (29.4%) developed bacterial VAP and 5
(9.8%) developed ARDS. Totally 20 patients (39.2%) were
improved versus 31 (60.8%) dead. More speciﬁcally, mortality
rate was higher in patients of geriatric ICU (80.6%) versus
(30%) in respiratory ICU patients.
Virological results
The overall rate of active CMV infection by RT-PCR among
the studied populations was (68.6%), (77.4%) in patients of
geriatric ICU versus (55%) in respiratory ICU patients.Table 1 Comparison between CMV positive and negative cases as
CMV
Yes
N %
Outcome Improved 9 25.7
Died 26 74.3
Septic shock Yes 6 17.1
No 29 82.9
ARDS Yes 5 14.3
No 30 85.7
VAP Yes 14 40.0
No 21 60.0
* Chi-square tests.
** Fisher’s exact test.
Table 2 Comparison between CMV positive and negative cases as
CMV
Yes
Mean ±SD Median
Duration of ventilation 4.60 3.19 4.00
Duration of ICU stay 8.14 6.99 6.00
Mann Whitney’s test.Comparison between CMV positive and negative cases
showed that there were no signiﬁcant differences in the demo-
graphic and clinical characteristics except for the duration of
mechanical ventilation, developing VAP and mortality rate
(Tables 1 and 2).
The present study showed a statistically higher CMV load
in respiratory ICU, patients admitted due to exacerbation of
chronic respiratory disease or stroke and developing VAP or
septic shock (Tables 3 and 4). Also there was a signiﬁcant di-
rect correlation between CMV load and age of the patient,
duration of mechanical ventilation and duration of ICU stay
(Table 5, Figs. 1 and 2).Discussion
CMV infection is common worldwide and affects 60–100% of
the adult population with a reported increase in prevalence
with age [7–9].
During recent years, CMV has been recognized as an
emerging pathogen in critically ill patients who are not receiv-
ing immunosuppressive therapy [10–14]. Critically ill patients
usually have severe immunologic impairment [15]. Active
CMV infection is likely to occur in this context of ‘‘ICU-ac-
quired immunosuppression’’ [16].
The present study showed that the overall rate of active
CMV infection by RT-PCR among the studied populations
was (68.6%), (77.4%) in patients of geriatric ICU versus
(55%) in respiratory ICU patients.
However, the incidence of active CMV infection is debated
[10,12,17]. Clinical trials examining the frequency of CMV
infection in ICU patients have not shown uniform results.
Serological positivity for CMV reported in critically ill patients
ranged from 13% [18] to 100% [17]. Some studies [11,12,18,19]regards outcome.
P* Sig
No
N %
11 68.8 .003* HS
5 31.3
0 .0 .159** NS
16 100.0
0 .0 .167** NS
16 100.0
1 6.3 019** S
15 93.8
regards duration of ventilation and ICU stay.
P Sig
No
Mean ±SD Median
2.50 .97 2.00 .001 HS
4.31 1.70 4.00 .079 NS
Table 3 Relation between risk factors and CMV load among all cases.
CMV load P Sig
Mean ±SD Median
Gender Male 9627.63 6470.09 11100.00 .297* NS
Female 6690.63 5066.76 4700.00
ICU Geriatric 6385.42 5255.81 4325.00 .007* HS
Respiratory 12429.55 5501.15 12800.00
Exacerbation of chronic respiratory disease Yes 10420.24 5904.37 11625.00 .007* HS
No 5082.14 4615.43 3675.00
Stroke Yes 4056.25 3563.35 2750.00 .014* S
No 9537.96 6010.22 8400.00
Cardiac diseases Yes 6790.00 5614.31 5700.00 .741* NS
No 8534.17 6086.73 6775.00
Others** Yes 5775.00 6399.32 5775.00 .477* NS
No 8437.12 6018.73 6300.00
DM Yes 9120.83 6227.74 7025.00 .487* NS
No 7848.91 5931.93 5600.00
Renal problem Yes 8796.15 6303.06 5700.00 .609* NS
No 7982.95 5901.47 6775.00
* Mann Whitney’s test.
** Others: (hepatic failure, dehydration and electrolyte disturbance).
Table 5 Correlations between age, duration of ventilation,
ICU stay and CMV load among all cases.
CMV load
Age
Rho .470
P .004
Sig HS
Duration of ventilation
Rho .478
P .004
Sig HS
Duration of ICU stay
Rho .562
P .0001
Sig HS
Table 4 Relation between CMV load and patients’ outcome among all cases.
CMV load P Sig
Mean ±SD Median
Outcome Improved 7991.67 6164.31 6300.00 .925* NS
Died 8386.54 6028.23 6250.00
Septic shock Yes 16291.67 2816.81 16400.00 .001* HS
No 6628.45 5034.27 4900.00
ARDS Yes 9770.00 4035.72 10300.00 .346* NS
No 8037.50 6257.43 5650.00
VAP Yes 12412.50 5437.70 13162.50 .001* HS
No 5533.33 4645.52 4150.00
* Mann Whitney’s test.
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[17,20–22] indicate very low or no CMV infection.
Coisel et al. [6] investigated Cytomegalovirus effect on the
prognosis of mechanically ventilated patients suspected tohave ventilator-associated pneumonia using RT-PCR. They
reported 22 patients (24%) were positive for CMV.
These discrepancies may be explained by study design differ-
ences, patient groups, and CMV infection diagnosis methods,
including viral culture, antigenemia and PCR assays. Previous
studies used culture-based assays (low sensitivity and time-con-
suming), whereas more recent studies have used antigenemia
(more sensitive and quantitative results) or PCR assays [24].
The higher frequency (77.4%) in patients of geriatric ICU
reported in this study is in agreement with Coisel et al. [6],
whose results showed that patients with positive CMV results
were older than patients with negative results.
The present work assessed the occurrence of CMV infection
and evaluated potential risk factors in ICU patients. There was
a signiﬁcant direct correlation between CMV load and age of
the patient. In the prospective study of Cook et al., [13] pa-
tients with active CMV infection were signiﬁcantly older than
those without CMV infection. Also in the study of Chiche
et al., [23] age was a risk factor for CMV infection. This
matched with Kanapeckien„ et al., [25] who reported that
the mechanisms associated with CMV infection have an
impact on immunosenescence. CMV reactivation occurs in
Figure 1 Correlations between duration of ventilation and CMV load among all cases.
Figure 2 Correlations between duration of ICU stay and CMV load among all cases.
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is a risk factor for CMV load in this study. One could argue
that the elderly present an increased risk of developing CMV
infection during critical illness because they are more likely
to have been previously exposed to CMV, or because immu-
nosenescence on the cellular immunity of elder patients may
favor reactivation of the latent virus during ICU stay [26].
The results of the present study showed that there were no sig-
niﬁcant differences between males and females as regards ac-
tive CMV infection. This is concordant with many studies
[10,12–14,18,19,24], who found that the association between
CMV infection and gender was inconsistent.
Comparison between CMV positive and negative cases
showed that there were no signiﬁcant differences in clinical
characteristics of the patients except for the duration of
mechanical ventilation, developing VAP and mortality rate.
This is in accordance with Jain et al. [27], who reported that
CMV reactivation in critically ill non-immunosuppressed pa-
tients leads to increased mortality and morbidity in terms of
increased ICU stay, longer duration of mechanical ventilation,
and higher rates of nosocomial infections.The present study showed a statistically higher CMV load
in respiratory ICU, patients admitted due to exacerbation of
chronic respiratory disease and developing VAP.
Though CMV can virtually affect any organ system, lungs
appear to be the most common organ of involvement. Lungs
act as a reservoir in cases of latent CMV infection and thus
act as the most consistent site for its reactivation [27]. Papazian
et al. [11] reported CMV as a causative agent of pneumonia
and all these patients had a more severe hypoxemia as com-
pared to others [11].
The present study showed a statistically higher CMV load
in patients admitted due to stroke. This might be explained
by the relation between CMV infection and changes in clotting
factors and the coagulation state. Also CNS manifestations are
very common in immunocompromised patients but there have
been reports of meningitis and other CNS manifestations as a
result of CMV even in immunocompetent patients [28]. In crit-
ically ill patients, 10% (2/20) of those with CMV infection
eventually developed severe CMV disease (pneumonitis, neu-
rologic disease) in one study [12]. CMV pneumonia has also
been diagnosed in 29 to 50% of patients with ARDS or
244 N.M. Osman et al.VAP [11,29,30], however, this does not necessarily mean that
CMV is the cause of ARDS or VAP. Critical illness due to seri-
ous pulmonary disease may predispose these patients to CMV
infection in the lungs [31].
The present study found signiﬁcantly high rates of CMV
infections in patients with severe sepsis/septic shock. Patients
with severe sepsis and/or septic shock are more prone to have
active CMV infections [19,28]. There are at least three biolog-
ical explanations for CMV reactivation in these non-immuno-
suppressed patients that could act alone or in combination: (1)
Patients with severe sepsis can develop a state called immunop-
aralysis, also called compensatory anti-inﬂammatory response
syndrome. (2) Bacterial sepsis itself can reactivate latent CMV
infection through endotoxin release by bacteria or tumor
necrosis factor- a production and (3) exogenous catecholamine
infusion can stimulate CMV activation [32,33]. Elevated tumor
necrosis factor-a, level in blood during systemic inﬂammatory
response syndrome might promote CMV reactivation by direct
stimulation of the CMV immediate-early enhancer/promoter
region [34], whereas acquired ICU immunosuppression,
termed compensatory anti-inﬂammatory response syndrome,
could permit an ‘‘immunoevasion’’ of the virus [35,36]
The present work showed that there was a signiﬁcant direct
correlation between CMV load and duration of mechanical
ventilation and duration of ICU stay. This is in agreement with
many studies which showed that the presence of CMV infection
in critically ill ICU patients led to increased length of ICU stay
and increased duration of mechanical ventilation as compared
to patients negative for CMV infections even when both the
groups had similar disease severity [10,13,14,24,37].
The present study showed that the CMV infected patients
also had higher mortality. The results of this study are concor-
dant with those of Heininger et al. [12], who found that the
mortality rate tended to be higher in patients with active
CMV infections, with a signiﬁcant increase in ICU length of
stay in survivors. Limaye et al. [24] also found an association
between CMV reactivation and a composite end point (pro-
longed hospitalization or death). Other studies also reported
that CMV infected patients had higher mortality as compared
to CMV negative patients [10,37]. Kalil et al.[38], reported that
the mortality rate associated with active CMV infection was
1.93 times as high as that for patients without infection.
CMV induces procoagulant and proinﬂammatory states by
its changes in factor X and thrombin generation as well as in
Von Willebrand factor and plasminogen inhibitor type 1 secre-
tion [39,40]. These procoagulant and proinﬂammatory effects
could further compromise the survival outcome of critically
ill patients. Thus many different studies have highlighted the
importance of CMV infection in ICU patients [12,14,28,37].
Limaye et al. [24] demonstrated an independent and quantita-
tive association between CMV viral load and prolonged length
of stay in a broad range of immunocompetent patients with
critical illness. These ﬁndings, combined with data from prior
investigations, provide a strong rationale for a randomized
controlled trial of antiviral prophylaxis in this clinical setting.Conclusions
CMV infection is frequent in mechanically ventilated critically
ill patients especially the elderly. It is associated with poor out-
comes, leads to increased mortality and morbidity in terms ofincreased ICU stay, longer duration of mechanical ventilation,
and higher rates of nosocomial infections. So it is important to
screen for active infection in those patients.
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